Search
ICON PLC
ICLRAdd to Watchlist
158.975USD
+16.305+11.43%
Market hours （ET）Quotes delayed by 15 min
12.17BMarket Cap
21.30P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+11.43%
5 Days
+10.75%
1 Month
+36.13%
6 Months
-13.16%
Year to Date
-12.76%
1 Year
+7.93%
Key Figures
147.790Open
160.760High
781.82KVolume
21.30P/E TTM
13.94P/E Dynamic
--Dividend TTM
1.02%Turnover Ratio
142.670Prev. Close
147.710Low
84.41MTurnover
15.38P/E Static
1.32P/B
0.00%Div Yield TTM
3.56%ROA
211.00052wk High
3.00Volume Ratio
791.47MNet Profit
76.57MShares
7.4645EPS TTM
1.26Beta
6.27%ROE
66.57052wk Low
9.15%Amplitude
18.73%Gross Margin
12.17BMarket Cap
7.02Reward/Risk
3.16%Risk Rate
TradingKey Stock Score of ICON PLC
Currency: USD Updated: 2026-06-23Key Insights
ICON PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 389 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 160.80.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ICON PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
ICON PLC Highlights
StrengthsRisks
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 8.25B.
Undervalued
The company’s latest PE is 19.11, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 83.08M shares, decreasing 15.66% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 2.80M shares of this stock.
Analyst Rating
Based on
18
analysts
Buy
Current Rating
160.800
Target Price
+14.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
ICON PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ICON PLC Info
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Ticker SymbolICLR
CompanyICON PLC
CEOBalfe (Barry Edward)
Websitehttps://www.iconplc.com/
Related Instruments
+0.16%
+0.52%
+1.01%
-0.34%
+0.36%
-0.12%
+1.56%
+0.11%
+0.31%
-1.48%
+1.78%
-0.27%
-1.14%
-0.08%
+1.22%
0.00%
+0.80%
+1.68%
-0.40%
-0.47%Popular Instruments
70.319
-2.626 (-3.60%)
297.935
+3.635 (+1.24%)
200.510
+0.470 (+0.23%)
4006.510
-104.240 (-2.54%)
647.000
-23.750 (-3.54%)
1909.760
-53.840 (-2.74%)
1030.240
-21.530 (-2.05%)
350.965
+4.835 (+1.40%)
60631.360
-1809.340 (-2.90%)
383.228
+1.618 (+0.42%)
FAQs
What is the current price of ICON PLC (ICLR)?
The current price of ICON PLC (ICLR) is 142.67.
What is the symbol of ICON PLC?
The ticker symbol of ICON PLC is ICLR.
What is the 52-week high of ICON PLC?
The 52-week high of ICON PLC is 211.00.
What is the 52-week low of ICON PLC?
The 52-week low of ICON PLC is 66.57.
What is the market capitalization of ICON PLC?
The market capitalization of ICON PLC is 10.92B.
Is ICON PLC (ICLR) currently rated as Buy, Hold, or Sell?
According to analysts, ICON PLC (ICLR) has an overall rating of Buy, with a price target of 160.80.
What is the Earnings Per Share (EPS TTM) of ICON PLC (ICLR)?
The Earnings Per Share (EPS TTM) of ICON PLC (ICLR) is 2.92.
